Revolutionary Gene Therapy Cures Type 1 Diabetes in 98% of Trial Patients as FDA Fast-Tracks Approval

A groundbreaking gene therapy has achieved what diabetes researchers thought impossible just five years ago: functional cures in 98% of Type 1 diabetes patients during Phase III trials. Vertex Pharmaceuticals’ VX-880 treatment, which reprograms patients’ own cells to produce insulin,…












